BioMarin Pharmaceutical Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
2,817.59 |
3,142.02 |
3,460.14 |
3,757.81 |
4,011.57 |
4,140.34 |
| Przychód Δ r/r |
0.00% |
11.51% |
10.12% |
8.60% |
6.75% |
3.21% |
| Przychód (min) |
2,797.61 |
3,017.99 |
3,192.43 |
3,757.50 |
3,828.34 |
3,951.23 |
| Przychód (max) |
2,827.58 |
3,276.38 |
3,723.12 |
3,758.12 |
4,198.14 |
4,332.91 |
| EBITDA (średnia) |
285.60 |
318.48 |
350.73 |
380.90 |
406.62 |
419.67 |
| EBIT (średnia) |
149.78 |
167.03 |
183.94 |
199.77 |
213.26 |
220.10 |
| EBIT % |
5.32% |
5.32% |
5.32% |
5.32% |
5.32% |
5.32% |
| Zysk netto (średni) |
444.77 |
663.72 |
857.42 |
1,028.57 |
1,242.76 |
1,370.56 |
| Zysk netto % |
15.79% |
21.12% |
24.78% |
27.37% |
30.98% |
33.10% |
| EPS (średnia) |
2.26 |
3.37 |
4.20 |
5.21 |
6.32 |
6.97 |
| Liczba analityków (Przychody) |
22 |
18 |
24 |
18 |
8 |
11 |
| Liczba analityków (EPS) |
18 |
18 |
19 |
13 |
9 |
11 |
| symbol |
BMRN |
BMRN |
BMRN |
BMRN |
BMRN |
BMRN |